Comparison of Hemodynamic Endpoints After Marrow Infusion
| . | Arm A (CD34+) . | Arm B (Buffy Coat) . | |
|---|---|---|---|
| . | (n = 42) . | (n = 47) . | |
| Infusional Toxicities . | Mean ± SD . | Mean ± SD . | P Value . |
| Maximum increase in systolic blood pressure (mm Hg) | 9 ± 11 | 22 ± 14 | P < .001 |
| Maximum increase in diastolic blood pressure (mm Hg) | 7 ± 7 | 16 ± 10 | P < .001 |
| Maximum decrease in heart rate (beats/min) | 9 ± 5 | 22 ± 11 | P < .001 |
| No. serious (grade IV) adverse events due to marrow infusion | 0 | 3 | P = .244 |
| . | Arm A (CD34+) . | Arm B (Buffy Coat) . | |
|---|---|---|---|
| . | (n = 42) . | (n = 47) . | |
| Infusional Toxicities . | Mean ± SD . | Mean ± SD . | P Value . |
| Maximum increase in systolic blood pressure (mm Hg) | 9 ± 11 | 22 ± 14 | P < .001 |
| Maximum increase in diastolic blood pressure (mm Hg) | 7 ± 7 | 16 ± 10 | P < .001 |
| Maximum decrease in heart rate (beats/min) | 9 ± 5 | 22 ± 11 | P < .001 |
| No. serious (grade IV) adverse events due to marrow infusion | 0 | 3 | P = .244 |